Dihydroartemisinin shift the immune response towards Th1, inhibit the tumor growth in vitro and in vivo
► DHA reduces tumor cell growth in RIN cell line, and also inhibits the growth of tumor tissue in vivo. ► Administration of DHA to tumor-bearing mice increases the level of IFN-γ and decreases the level of IL-4. ► Administration of DHA to tumor-bearing mice decreases the level of splenic CD4+CD25+ F...
Gespeichert in:
| Veröffentlicht in: | Cellular immunology 2011, Vol.271 (1), p.67-72 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 72 |
|---|---|
| container_issue | 1 |
| container_start_page | 67 |
| container_title | Cellular immunology |
| container_volume | 271 |
| creator | Noori, Shokoofe Hassan, Zuhair M. |
| description | ► DHA reduces tumor cell growth in RIN cell line, and also inhibits the growth of tumor tissue in vivo. ► Administration of DHA to tumor-bearing mice increases the level of IFN-γ and decreases the level of IL-4. ► Administration of DHA to tumor-bearing mice decreases the level of splenic CD4+CD25+ FOXP3+ regulatory T cells. ► By using an appropriate dose of DHA, new therapeutic aspects of this medicine in cancer therapy will be elucidated.
Some investigators have been found that Artemisinin and its derivates have inhibitory effect on growth of cancer cells. Among these derivatives, Dihydroartemisinin (DHA) is well known as a semi-synthetic one. In addition, T cells are proved to be essential for the destruction of cancer cells. In this research, we assessed the effects of DHA on tumor cell growth inhibition in vitro by MTT assay and in vivo by intra tumor injection of DHA against breast cancer. The results showed that the IC50 values of DHA for RIN pancreatic tumor cell line were 30μM and significant decrease in the tumor size in vivo. Also we evaluate the effect of DHA on the modulation of immune response in tumor bearing animals; these include the splenocyte proliferation using the BrdU kit; measurement of cytokine profile by ELISA, and evaluate the percentage of T regulatory cells in the spleen by flowcytometry. Our results demonstrated that a significant decrease in the level of IL-4 in the animals treated with DHA and significant decreased in the level of splenic CD4+CD25+ Foxp3+ T regulatory cells. |
| doi_str_mv | 10.1016/j.cellimm.2011.06.008 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_904495329</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0008874911001468</els_id><sourcerecordid>904495329</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-995fda23df28f7161729d536d20dedcabdd02997544fdec81179821ec22bbec93</originalsourceid><addsrcrecordid>eNqFkE1v2zAMhoWhw5pm-wkrdOtl9ij5U6ehSNduQIBdsrNgS3SsILZSSU6Qfz8FznrtiRD1vCT4EPKVQcqAld93qcL93gxDyoGxFMoUoP5AFgwEJJyV2Q1ZQGwldZWLW3Ln_Q4imAv4RG45q2MKygXZPpn-rJ1tXMDBeDOakfredIGGHmkcP41IHfqDHT3SYE-N055uevaNmrE3rZnBMA3W0a2zp9DHD3o0wVnajHp-HO1n8rFr9h6_XOuS_H3-uVn9StZ_Xn6vHteJykQZEiGKTjc80x2vu4qVrOJCF1mpOWjUqmm1Bi5EVeR5p1HVjFWi5gwV522LSmRL8jDPPTj7OqEPMl51MdWMaCcvBeS5KDJ-IYuZVM5677CTB2eGxp0lA3lRLHfyqlheFEsoZfQZc_fXDVM7oH5L_XcagR8zgPHOo0EnvTI4KtTGoQpSW_POin_Iu5E8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>904495329</pqid></control><display><type>article</type><title>Dihydroartemisinin shift the immune response towards Th1, inhibit the tumor growth in vitro and in vivo</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Noori, Shokoofe ; Hassan, Zuhair M.</creator><creatorcontrib>Noori, Shokoofe ; Hassan, Zuhair M.</creatorcontrib><description>► DHA reduces tumor cell growth in RIN cell line, and also inhibits the growth of tumor tissue in vivo. ► Administration of DHA to tumor-bearing mice increases the level of IFN-γ and decreases the level of IL-4. ► Administration of DHA to tumor-bearing mice decreases the level of splenic CD4+CD25+ FOXP3+ regulatory T cells. ► By using an appropriate dose of DHA, new therapeutic aspects of this medicine in cancer therapy will be elucidated.
Some investigators have been found that Artemisinin and its derivates have inhibitory effect on growth of cancer cells. Among these derivatives, Dihydroartemisinin (DHA) is well known as a semi-synthetic one. In addition, T cells are proved to be essential for the destruction of cancer cells. In this research, we assessed the effects of DHA on tumor cell growth inhibition in vitro by MTT assay and in vivo by intra tumor injection of DHA against breast cancer. The results showed that the IC50 values of DHA for RIN pancreatic tumor cell line were 30μM and significant decrease in the tumor size in vivo. Also we evaluate the effect of DHA on the modulation of immune response in tumor bearing animals; these include the splenocyte proliferation using the BrdU kit; measurement of cytokine profile by ELISA, and evaluate the percentage of T regulatory cells in the spleen by flowcytometry. Our results demonstrated that a significant decrease in the level of IL-4 in the animals treated with DHA and significant decreased in the level of splenic CD4+CD25+ Foxp3+ T regulatory cells.</description><identifier>ISSN: 0008-8749</identifier><identifier>EISSN: 1090-2163</identifier><identifier>DOI: 10.1016/j.cellimm.2011.06.008</identifier><identifier>PMID: 21820106</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Animals ; Antimalarials - administration & dosage ; Antimalarials - pharmacology ; Artemisinins - administration & dosage ; Artemisinins - pharmacology ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Cell Survival - drug effects ; Cell Survival - immunology ; Dihydroartemisinin ; Dose-Response Relationship, Drug ; Female ; Hindlimb - drug effects ; Hindlimb - immunology ; Hypersensitivity, Delayed - immunology ; IFN-γ ; IL-4 ; Immuno-modulator ; Inhibitory Concentration 50 ; Injections, Intraperitoneal ; Interferon-gamma - immunology ; Interferon-gamma - metabolism ; Interleukin-4 - immunology ; Interleukin-4 - metabolism ; Mammary Neoplasms, Experimental - immunology ; Mammary Neoplasms, Experimental - pathology ; Mammary Neoplasms, Experimental - prevention & control ; Mice ; Mice, Inbred BALB C ; Sheep ; T regulatory cell (Treg cell) ; T-Lymphocytes - drug effects ; T-Lymphocytes - immunology ; T-Lymphocytes - metabolism ; T-Lymphocytes, Regulatory - drug effects ; T-Lymphocytes, Regulatory - immunology ; T-Lymphocytes, Regulatory - metabolism ; Th1 Cells - drug effects ; Th1 Cells - immunology ; Th1 Cells - metabolism ; Tumor Burden - drug effects ; Tumor Burden - immunology</subject><ispartof>Cellular immunology, 2011, Vol.271 (1), p.67-72</ispartof><rights>2011</rights><rights>Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-995fda23df28f7161729d536d20dedcabdd02997544fdec81179821ec22bbec93</citedby><cites>FETCH-LOGICAL-c396t-995fda23df28f7161729d536d20dedcabdd02997544fdec81179821ec22bbec93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.cellimm.2011.06.008$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,4024,27923,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21820106$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Noori, Shokoofe</creatorcontrib><creatorcontrib>Hassan, Zuhair M.</creatorcontrib><title>Dihydroartemisinin shift the immune response towards Th1, inhibit the tumor growth in vitro and in vivo</title><title>Cellular immunology</title><addtitle>Cell Immunol</addtitle><description>► DHA reduces tumor cell growth in RIN cell line, and also inhibits the growth of tumor tissue in vivo. ► Administration of DHA to tumor-bearing mice increases the level of IFN-γ and decreases the level of IL-4. ► Administration of DHA to tumor-bearing mice decreases the level of splenic CD4+CD25+ FOXP3+ regulatory T cells. ► By using an appropriate dose of DHA, new therapeutic aspects of this medicine in cancer therapy will be elucidated.
Some investigators have been found that Artemisinin and its derivates have inhibitory effect on growth of cancer cells. Among these derivatives, Dihydroartemisinin (DHA) is well known as a semi-synthetic one. In addition, T cells are proved to be essential for the destruction of cancer cells. In this research, we assessed the effects of DHA on tumor cell growth inhibition in vitro by MTT assay and in vivo by intra tumor injection of DHA against breast cancer. The results showed that the IC50 values of DHA for RIN pancreatic tumor cell line were 30μM and significant decrease in the tumor size in vivo. Also we evaluate the effect of DHA on the modulation of immune response in tumor bearing animals; these include the splenocyte proliferation using the BrdU kit; measurement of cytokine profile by ELISA, and evaluate the percentage of T regulatory cells in the spleen by flowcytometry. Our results demonstrated that a significant decrease in the level of IL-4 in the animals treated with DHA and significant decreased in the level of splenic CD4+CD25+ Foxp3+ T regulatory cells.</description><subject>Animals</subject><subject>Antimalarials - administration & dosage</subject><subject>Antimalarials - pharmacology</subject><subject>Artemisinins - administration & dosage</subject><subject>Artemisinins - pharmacology</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Cell Survival - drug effects</subject><subject>Cell Survival - immunology</subject><subject>Dihydroartemisinin</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>Hindlimb - drug effects</subject><subject>Hindlimb - immunology</subject><subject>Hypersensitivity, Delayed - immunology</subject><subject>IFN-γ</subject><subject>IL-4</subject><subject>Immuno-modulator</subject><subject>Inhibitory Concentration 50</subject><subject>Injections, Intraperitoneal</subject><subject>Interferon-gamma - immunology</subject><subject>Interferon-gamma - metabolism</subject><subject>Interleukin-4 - immunology</subject><subject>Interleukin-4 - metabolism</subject><subject>Mammary Neoplasms, Experimental - immunology</subject><subject>Mammary Neoplasms, Experimental - pathology</subject><subject>Mammary Neoplasms, Experimental - prevention & control</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Sheep</subject><subject>T regulatory cell (Treg cell)</subject><subject>T-Lymphocytes - drug effects</subject><subject>T-Lymphocytes - immunology</subject><subject>T-Lymphocytes - metabolism</subject><subject>T-Lymphocytes, Regulatory - drug effects</subject><subject>T-Lymphocytes, Regulatory - immunology</subject><subject>T-Lymphocytes, Regulatory - metabolism</subject><subject>Th1 Cells - drug effects</subject><subject>Th1 Cells - immunology</subject><subject>Th1 Cells - metabolism</subject><subject>Tumor Burden - drug effects</subject><subject>Tumor Burden - immunology</subject><issn>0008-8749</issn><issn>1090-2163</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1v2zAMhoWhw5pm-wkrdOtl9ij5U6ehSNduQIBdsrNgS3SsILZSSU6Qfz8FznrtiRD1vCT4EPKVQcqAld93qcL93gxDyoGxFMoUoP5AFgwEJJyV2Q1ZQGwldZWLW3Ln_Q4imAv4RG45q2MKygXZPpn-rJ1tXMDBeDOakfredIGGHmkcP41IHfqDHT3SYE-N055uevaNmrE3rZnBMA3W0a2zp9DHD3o0wVnajHp-HO1n8rFr9h6_XOuS_H3-uVn9StZ_Xn6vHteJykQZEiGKTjc80x2vu4qVrOJCF1mpOWjUqmm1Bi5EVeR5p1HVjFWi5gwV522LSmRL8jDPPTj7OqEPMl51MdWMaCcvBeS5KDJ-IYuZVM5677CTB2eGxp0lA3lRLHfyqlheFEsoZfQZc_fXDVM7oH5L_XcagR8zgPHOo0EnvTI4KtTGoQpSW_POin_Iu5E8</recordid><startdate>2011</startdate><enddate>2011</enddate><creator>Noori, Shokoofe</creator><creator>Hassan, Zuhair M.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>2011</creationdate><title>Dihydroartemisinin shift the immune response towards Th1, inhibit the tumor growth in vitro and in vivo</title><author>Noori, Shokoofe ; Hassan, Zuhair M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-995fda23df28f7161729d536d20dedcabdd02997544fdec81179821ec22bbec93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Antimalarials - administration & dosage</topic><topic>Antimalarials - pharmacology</topic><topic>Artemisinins - administration & dosage</topic><topic>Artemisinins - pharmacology</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Cell Survival - drug effects</topic><topic>Cell Survival - immunology</topic><topic>Dihydroartemisinin</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>Hindlimb - drug effects</topic><topic>Hindlimb - immunology</topic><topic>Hypersensitivity, Delayed - immunology</topic><topic>IFN-γ</topic><topic>IL-4</topic><topic>Immuno-modulator</topic><topic>Inhibitory Concentration 50</topic><topic>Injections, Intraperitoneal</topic><topic>Interferon-gamma - immunology</topic><topic>Interferon-gamma - metabolism</topic><topic>Interleukin-4 - immunology</topic><topic>Interleukin-4 - metabolism</topic><topic>Mammary Neoplasms, Experimental - immunology</topic><topic>Mammary Neoplasms, Experimental - pathology</topic><topic>Mammary Neoplasms, Experimental - prevention & control</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Sheep</topic><topic>T regulatory cell (Treg cell)</topic><topic>T-Lymphocytes - drug effects</topic><topic>T-Lymphocytes - immunology</topic><topic>T-Lymphocytes - metabolism</topic><topic>T-Lymphocytes, Regulatory - drug effects</topic><topic>T-Lymphocytes, Regulatory - immunology</topic><topic>T-Lymphocytes, Regulatory - metabolism</topic><topic>Th1 Cells - drug effects</topic><topic>Th1 Cells - immunology</topic><topic>Th1 Cells - metabolism</topic><topic>Tumor Burden - drug effects</topic><topic>Tumor Burden - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Noori, Shokoofe</creatorcontrib><creatorcontrib>Hassan, Zuhair M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Cellular immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Noori, Shokoofe</au><au>Hassan, Zuhair M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dihydroartemisinin shift the immune response towards Th1, inhibit the tumor growth in vitro and in vivo</atitle><jtitle>Cellular immunology</jtitle><addtitle>Cell Immunol</addtitle><date>2011</date><risdate>2011</risdate><volume>271</volume><issue>1</issue><spage>67</spage><epage>72</epage><pages>67-72</pages><issn>0008-8749</issn><eissn>1090-2163</eissn><abstract>► DHA reduces tumor cell growth in RIN cell line, and also inhibits the growth of tumor tissue in vivo. ► Administration of DHA to tumor-bearing mice increases the level of IFN-γ and decreases the level of IL-4. ► Administration of DHA to tumor-bearing mice decreases the level of splenic CD4+CD25+ FOXP3+ regulatory T cells. ► By using an appropriate dose of DHA, new therapeutic aspects of this medicine in cancer therapy will be elucidated.
Some investigators have been found that Artemisinin and its derivates have inhibitory effect on growth of cancer cells. Among these derivatives, Dihydroartemisinin (DHA) is well known as a semi-synthetic one. In addition, T cells are proved to be essential for the destruction of cancer cells. In this research, we assessed the effects of DHA on tumor cell growth inhibition in vitro by MTT assay and in vivo by intra tumor injection of DHA against breast cancer. The results showed that the IC50 values of DHA for RIN pancreatic tumor cell line were 30μM and significant decrease in the tumor size in vivo. Also we evaluate the effect of DHA on the modulation of immune response in tumor bearing animals; these include the splenocyte proliferation using the BrdU kit; measurement of cytokine profile by ELISA, and evaluate the percentage of T regulatory cells in the spleen by flowcytometry. Our results demonstrated that a significant decrease in the level of IL-4 in the animals treated with DHA and significant decreased in the level of splenic CD4+CD25+ Foxp3+ T regulatory cells.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>21820106</pmid><doi>10.1016/j.cellimm.2011.06.008</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-8749 |
| ispartof | Cellular immunology, 2011, Vol.271 (1), p.67-72 |
| issn | 0008-8749 1090-2163 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_904495329 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Animals Antimalarials - administration & dosage Antimalarials - pharmacology Artemisinins - administration & dosage Artemisinins - pharmacology Cell Line, Tumor Cell Proliferation - drug effects Cell Survival - drug effects Cell Survival - immunology Dihydroartemisinin Dose-Response Relationship, Drug Female Hindlimb - drug effects Hindlimb - immunology Hypersensitivity, Delayed - immunology IFN-γ IL-4 Immuno-modulator Inhibitory Concentration 50 Injections, Intraperitoneal Interferon-gamma - immunology Interferon-gamma - metabolism Interleukin-4 - immunology Interleukin-4 - metabolism Mammary Neoplasms, Experimental - immunology Mammary Neoplasms, Experimental - pathology Mammary Neoplasms, Experimental - prevention & control Mice Mice, Inbred BALB C Sheep T regulatory cell (Treg cell) T-Lymphocytes - drug effects T-Lymphocytes - immunology T-Lymphocytes - metabolism T-Lymphocytes, Regulatory - drug effects T-Lymphocytes, Regulatory - immunology T-Lymphocytes, Regulatory - metabolism Th1 Cells - drug effects Th1 Cells - immunology Th1 Cells - metabolism Tumor Burden - drug effects Tumor Burden - immunology |
| title | Dihydroartemisinin shift the immune response towards Th1, inhibit the tumor growth in vitro and in vivo |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T03%3A12%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dihydroartemisinin%20shift%20the%20immune%20response%20towards%20Th1,%20inhibit%20the%20tumor%20growth%20in%20vitro%20and%20in%20vivo&rft.jtitle=Cellular%20immunology&rft.au=Noori,%20Shokoofe&rft.date=2011&rft.volume=271&rft.issue=1&rft.spage=67&rft.epage=72&rft.pages=67-72&rft.issn=0008-8749&rft.eissn=1090-2163&rft_id=info:doi/10.1016/j.cellimm.2011.06.008&rft_dat=%3Cproquest_cross%3E904495329%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=904495329&rft_id=info:pmid/21820106&rft_els_id=S0008874911001468&rfr_iscdi=true |